KO-202125, a sauristolactam derivate, induces apoptosis to prevent KB human oral squamous carcinoma cells through inhibition of cyclooxygenase-2 expression. (Q43243067)
Jump to navigation
Jump to search
scientific article published in January 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | KO-202125, a sauristolactam derivate, induces apoptosis to prevent KB human oral squamous carcinoma cells through inhibition of cyclooxygenase-2 expression. |
scientific article published in January 2010 |
Statements
KO-202125, a sauristolactam derivate, induces apoptosis to prevent KB human oral squamous carcinoma cells through inhibition of cyclooxygenase-2 expression (English)
Dae-Ho Leem
Kyeong-Hee Choi
Hye-Suk Han
Jun-Hee Kim
Ji-Ae Shin
Eun-Sun Choi
Gu Kong
Yong-Ki Min
Jeong-Seok Nam
Seung Hyun Oh
Kyoung-A Kim
Ki Han Kwon
Nam-Pyo Cho